Scout | HEAL UG3/UH3 program to develop non-addictive pain therapeutics (small molecules and biologics)

This opportunity is no longer accepting applications.

grant

HEAL UG3/UH3 program to develop non-addictive pain therapeutics (small molecules and biologics)

This NIH HEAL Initiative NOFO funds early-stage optimization and IND-enabling work to develop safe, effective, and non-addictive pain treatments. Projects can include lead optimization, biomarker development, IND preparation, and Phase I testing, using milestone-driven cooperative agreement support. Applicants must propose a promising lead candidate with a strong biological rationale and estab…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Program: National Institute of Neurological Disorders and Stroke

Dates

Release Date: June 16, 2026

Expiration Date: February 21, 2029

Keywords

non-addictive pain

therapeutic development

small molecules

biologics

lead optimization

ind enabling

phase 1 clinical

heal initiative

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers